Upcoming Catalysts On The Radar: ARQL & GBT

ASH abstracts coming 12/1. Looking forward to $ARQL update on reversible Btk inhib ARQ 531 for C481S mutants (Ibrutinib resistance) in B cell cancers and $GBT Hope Kids higher dose cohort for Voxelotor/sickle cell.

Click to see info on more upcoming small biopharma catalyst events.